Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia. (Q39585342)
Jump to navigation
Jump to search
scientific article published on 25 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia. |
scientific article published on 25 February 2011 |
Statements
Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia (English)
Irene M Ghobrial
Abdel Kareem Azab
Feda Azab
Ghayas C Issa
Brittany Morgan
Yang Liu
Yong Zhang
Hai T Ngo
25 February 2011